Literature DB >> 9107348

Natural history of Menière's disease: staging the patients or their symptoms?

R Filipo1, M Barbara.   

Abstract

The issue of what can be considered "natural" in the evolution of Menière's disease is reassessed in terms of basic assumptions regarding the definition of this inner ear disorder. Strict principles for the identification of Menière's patients are recommended; i.e. episodic vertigo, fluctuating-ascending hearing loss and tinnitus, accompanied by a positive electrocochleographic pattern (summating/action potential ratio > 0.51). When considering the evolution of Menière's disease, it is worth stressing that almost all patients receive several different kinds of treatment which affect the natural course of the disease to different degrees. When staging the patients, a prodromic stage (Stage 0), with intermittent, isolated symptoms of variable duration, precedes the disabling stage (Stage I) with its full array of symptoms. Stage la can be distinguished from Stage Ib depending on the fluctuation in hearing and different therapeutic strategies can be proposed in order to reach the stabilised stage (Stage II). A limited number of patients are susceptible to either reverting into a disabling stage or progressing to Stage III, with possible involvement of the contralateral ear. We conclude that the full expression of the disease is a self-running course which can be only slightly modified by medical or surgical therapy but, instead, can be controlled by psychological counselling and dietary-hygienic principles.

Entities:  

Mesh:

Year:  1997        PMID: 9107348     DOI: 10.3109/00016489709124013

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  8 in total

1.  A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3.

Authors:  K Fukushima; N Kasai; Y Ueki; K Nishizaki; K Sugata; S Hirakawa; A Masuda; M Gunduz; Y Ninomiya; Y Masuda; M Sato; W T McGuirt; P Coucke; G Van Camp; R J Smith
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Surgical indication in Menière's disease therapy: clinical and epidemiological aspects.

Authors:  Roberto Albera; Andrea Canale; Fiorella Parandero; Alessandro Ducati; Michele Lanotte
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-19       Impact factor: 2.503

3.  Summating potential & summating potential/action potential ratio in the diagnosis of Meniere's disease.

Authors:  B Jaimanti Bakshi; A K Gupta; S B Mann
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2001-07

4.  Disability perception in Menière's disease: when, how much and why?

Authors:  Andres Soto-Varela; Belen Huertas-Pardo; Pilar Gayoso-Diz; Sofia Santos-Perez; Ines Sanchez-Sellero
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-01       Impact factor: 2.503

5.  Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.

Authors:  A D Olusesi; S B Hassan; Y Oyeyipo; U C Ukwuije; O Oyeniran
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-26       Impact factor: 2.503

6.  Usefulness of Ultrasound-Computer-Craniocorpography in Unilateral Ménière's Disease.

Authors:  Stephanie Maihoub; László Tamás; András Molnár; Agnes Szirmai
Journal:  Biomed Hub       Date:  2019-05-13

7.  Betahistine in the treatment of Ménière's disease.

Authors:  Michel Lacour; Paul H van de Heyning; Miroslav Novotny; Brahim Tighilet
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

8.  The outcome of patients with Ménières disease.

Authors:  Adriana Gonzaga Chaves; Letícia Boari; Mário Sérgio Lei Munhoz
Journal:  Braz J Otorhinolaryngol       Date:  2007 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.